Academic Journal
View in EDS

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

Bibliographic Details
Title: Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
Authors: Melani, Christopher, Dowdell, Kennichi, Pittaluga, Stefania, Dunleavy, Kieron, Roschewski, Mark, Song, Joo Y, Calattini, Sara, Kawada, Jun-ichi, Price, David A, Chattopadhyay, Pratip K, Roederer, Mario, Lucas, Andrea N, Steinberg, Seth M, Jaffe, Elaine S, Cohen, Jeffrey I, Wilson, Wyndham H *
Source: In The Lancet Haematology May 2023 10(5):e346-e358
Database: ScienceDirect
More Details
ISSN:23523026
DOI:10.1016/S2352-3026(23)00029-7
Published in:The Lancet Haematology
Language:English